Rockwell Medical (NASDAQ:RMTI) Posts Earnings Results, Misses Expectations By $0.04 EPS

Rockwell Medical (NASDAQ:RMTI) posted its quarterly earnings data on Thursday. The company reported ($0.02) EPS for the quarter, missing analysts’ consensus estimates of $0.02 by ($0.04), Zacks reports. Rockwell Medical had a negative net margin of 1.25% and a positive return on equity of 8.55%. Rockwell Medical updated its FY 2025 guidance to EPS.

Rockwell Medical Stock Down 16.8 %

Shares of RMTI opened at $1.47 on Thursday. The company has a debt-to-equity ratio of 0.33, a quick ratio of 2.00 and a current ratio of 2.41. The stock has a 50 day moving average price of $1.88 and a 200 day moving average price of $2.63. The stock has a market capitalization of $47.35 million, a price-to-earnings ratio of -29.10 and a beta of 1.55. Rockwell Medical has a one year low of $1.34 and a one year high of $5.15.

Wall Street Analysts Forecast Growth

Several analysts recently commented on RMTI shares. StockNews.com cut Rockwell Medical from a “buy” rating to a “hold” rating in a research report on Friday, December 20th. HC Wainwright reiterated a “buy” rating and set a $7.00 price target on shares of Rockwell Medical in a research report on Monday, December 23rd.

About Rockwell Medical

Rockwell Medical, Inc, together with its subsidiaries, operates as a healthcare company that engages in the development, manufacture, commercialization, and distribution of various hemodialysis products for dialysis providers worldwide. The company offers Triferic Dialysate and Triferic AVNU which are indicated to maintain hemoglobin in adult undergoing hemodialysis.